Clinical Trial Update: A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of AGS-16M18 in subjects with advanced renal cell carcinoma; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Neoplasms
• Renal Cell Carcinoma

Drugs mentioned

• AGS-16M18

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Carcinoma, Renal Cell, Kidney Neoplasms | Phase 1 | Status: TERMINATED